X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (7) 7
colorectal cancer (5) 5
medical research (5) 5
oncology (5) 5
cancer (4) 4
colorectal neoplasms - pathology (4) 4
genetics (4) 4
prognosis (4) 4
antineoplastic agents - therapeutic use (3) 3
cancer patients (3) 3
care and treatment (3) 3
colorectal neoplasms - drug therapy (3) 3
colorectal neoplasms - genetics (3) 3
internal medicine (3) 3
research (3) 3
1st-line treatment (2) 2
abridged index medicus (2) 2
aged (2) 2
biomarkers, tumor - genetics (2) 2
cancer research (2) 2
cancer therapies (2) 2
cell cycle (2) 2
clinical trials (2) 2
colorectal carcinoma (2) 2
colorectal neoplasms - mortality (2) 2
disease-free survival (2) 2
dosage and administration (2) 2
drug resistance (2) 2
drug therapy (2) 2
female (2) 2
fluorouracil (2) 2
gene expression profiling (2) 2
gene expression regulation, neoplastic (2) 2
genetic aspects (2) 2
male (2) 2
medicine, experimental (2) 2
medicine, general & internal (2) 2
metastasis (2) 2
middle aged (2) 2
multicenter randomized-trial (2) 2
patients (2) 2
phenotype (2) 2
phenylurea compounds - therapeutic use (2) 2
proteins (2) 2
pyridines - therapeutic use (2) 2
quality-of-life (2) 2
research article (2) 2
survival (2) 2
thymidylate synthase (2) 2
treatment outcome (2) 2
5-fluorouracil chemotherapy (1) 1
acetylation (1) 1
acquired-resistance (1) 1
adenocarcinoma (1) 1
adenocarcinoma - blood (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - secondary (1) 1
analysis system rias (1) 1
antimetabolites, antineoplastic - pharmacology (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antisense transcription (1) 1
apoptosis (1) 1
bioindicators (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - blood (1) 1
biopsy (1) 1
breast-cancer (1) 1
cancer genetics (1) 1
care providers (1) 1
cediranib (1) 1
cell line, tumor (1) 1
cell proliferation (1) 1
cell survival - drug effects (1) 1
cetuximab plus irinotecan (1) 1
chemotherapy (1) 1
class i phosphatidylinositol 3-kinases (1) 1
clinical trials, phase iii as topic (1) 1
clinical-practice (1) 1
clinical-trials (1) 1
colon (1) 1
colon cancer (1) 1
colon-cancer (1) 1
colonic neoplasms - enzymology (1) 1
colonic neoplasms - genetics (1) 1
colonic neoplasms - pathology (1) 1
colorectal neoplasms - blood (1) 1
colorectal neoplasms - diagnosis (1) 1
colorectal neoplasms - therapy (1) 1
combined modality therapy (1) 1
communication (1) 1
concordance (1) 1
consultations (1) 1
cytotoxicity (1) 1
decision making (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 937 - 948
Summary Background Tumour mutational status is an important determinant of the response of metastatic colorectal cancer to targeted treatments. However, the... 
Hematology, Oncology and Palliative Medicine | KRAS MUTATIONS | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | RANDOMIZED PHASE-III | INHIBITS GROWTH | ACQUIRED-RESISTANCE | FLUOROURACIL | PLACEBO PLUS | TUMOR-GROWTH | Predictive Value of Tests | Proto-Oncogene Proteins p21(ras) | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Clinical Trials, Phase III as Topic | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Precision Medicine | Receptor, TIE-1 - blood | Phosphatidylinositol 3-Kinases - blood | Genetic Predisposition to Disease | Adenocarcinoma - blood | ras Proteins - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Phenotype | Class I Phosphatidylinositol 3-Kinases | Biomarkers, Tumor - genetics | ras Proteins - genetics | Patient Selection | DNA, Neoplasm - blood | Female | Adenocarcinoma - genetics | Retrospective Studies | Pyridines - therapeutic use | Colorectal Neoplasms - mortality | Colorectal Neoplasms - blood | Kaplan-Meier Estimate | Proportional Hazards Models | Phenylurea Compounds - therapeutic use | Proto-Oncogene Proteins B-raf - blood | Proto-Oncogene Proteins - genetics | Treatment Outcome | Randomized Controlled Trials as Topic | Biomarkers, Tumor - blood | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Proto-Oncogene Proteins B-raf - genetics | Aged | DNA, Neoplasm - genetics | Colorectal Neoplasms - pathology | Proto-Oncogene Proteins - blood | Adenocarcinoma - mortality | Medical colleges | Medical research | Cancer patients | Prognosis | Liver | DNA | Colorectal cancer | Genetic research | Medicine, Experimental | Metastasis
Journal Article
Journal Article
Journal Article
by Jiang, Xia and Finucane, Hilary K and Schumacher, Fredrick R and Schmit, Stephanie L and Tyrer, Jonathan P and Han, Younghun and Michailidou, Kyriaki and Lesseur, Corina and Kuchenbaecker, Karoline B and Dennis, Joe and Conti, David V and Casey, Graham and Gaudet, Mia M and Huyghe, Jeroen R and Albanes, Demetrius and Aldrich, Melinda C and Andrew, Angeline S and Andrulis, Irene L and Anton-Culver, Hoda and Antoniou, Antonis C and Antonenkova, Natalia N and Arnold, Susanne M and Aronson, Kristan J and Arun, Banu K and Bandera, Elisa V and Barkardottir, Rosa B and Barnes, Daniel R and Batra, Jyotsna and Beckmann, Matthias W and Benitez, Javier and Benlloch, Sara and Berchuck, Andrew and Berndt, Sonja I and Bickeböller, Heike and Bien, Stephanie A and Blomqvist, Carl and Boccia, Stefania and Bogdanova, Natalia V and Bojesen, Stig E and Bolla, Manjeet K and Brauch, Hiltrud and Brenner, Hermann and Brenton, James D and Brook, Mark N and Brunet, Joan and Brunnström, Hans and Buchanan, Daniel D and Burwinkel, Barbara and Butzow, Ralf and Cadoni, Gabriella and Caldés, Trinidad and Caligo, Maria A and Campbell, Ian and Campbell, Peter T and Cancel-Tassin, Géraldine and Cannon-Albright, Lisa and Campa, Daniele and Caporaso, Neil and Carvalho, André L and Chan, Andrew T and Chang-Claude, Jenny and Chanock, Stephen J and Chen, Chu and Christiani, David C and Claes, Kathleen B. M and Claessens, Frank and Clements, Judith and Collée, J. Margriet and Correa, Marcia Cruz and Couch, Fergus J and Cox, Angela and Cunningham, Julie M and Cybulski, Cezary and Czene, Kamila and Daly, Mary B and deFazio, Anna and Devilee, Peter and Diez, Orland and Gago-Dominguez, Manuela and Donovan, Jenny L and Dörk, Thilo and Duell, Eric J and Dunning, Alison M and Dwek, Miriam and Eccles, Diana M and Edlund, Christopher K and Edwards, Digna R. Velez and Ellberg, Carolina and Evans, D. Gareth and Fasching, Peter A and Ferris, Robert L and Liloglou, Triantafillos and Figueiredo, Jane C and Fletcher, Olivia and Fortner, Renée T and Fostira, Florentia and Franceschi, Silvia and Friedman, Eitan and Gallinger, Steven J and Ganz, Patricia A and ...
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 1 - 8
An amendment to this paper has been published and can be accessed via a link at the top of the paper. 
Heritability
Journal Article
BMC Cancer, ISSN 1471-2407, 12/2010, Volume 10, Issue 1, pp. 687 - 687
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.